Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties

Mar 1, 2017International journal of molecular sciences

Reducing Heat Shock Factor 1 Makes A172 Brain Cancer Cells More Sensitive to Temozolomide by Lowering Stem Cell-Like Traits

AI simplified

Abstract

Knockdown of or may enhance apoptosis and reduce cancer stem-like properties in .

  • HSF1 regulates key processes like cell growth and death by activating genes linked to stress response.
  • Depletion of BIS led to decreased levels and nuclear localization of HSF1 under conditions that mimic glioblastoma stem cell growth.
  • Knockdown of HSF1 resulted in reduced expression of SOX2, a marker associated with stemness, and impaired sphere-forming ability.
  • Combined knockdown of HSF1 or BIS with the chemotherapy drug temozolomide increased signs of cell death.
  • The reduction in cancer stem-like traits, such as colony-forming ability and SOX2 expression, was observed following knockdown and drug treatment.

AI simplified

Key numbers

50 nM
Increase in TMZ Sensitivity
Concentration of siRNA used to deplete in glioblastoma cells.
668 μM
Decrease in SOX2 Expression
Concentration of temozolomide that further decreased SOX2 expression in -depleted cells.

Full Text

What this is

  • This research investigates the role of () in () and their resistance to temozolomide (TMZ).
  • is linked to cancer stem cell-like properties and is regulated by the ().
  • The study explores how depleting or can enhance the sensitivity of to TMZ, a standard treatment for glioblastoma.

Essence

  • Depleting or in increases their sensitivity to temozolomide, reducing cancer stem cell-like properties and promoting apoptosis.

Key takeaways

  • depletion significantly decreases its protein levels in , particularly under sphere-forming conditions. This reduction is accompanied by decreased nuclear localization of , which is crucial for its function.
  • Combining or depletion with TMZ treatment enhances apoptosis in . This combination leads to decreased expression of SOX2, a marker of stemness, and reduced colony-forming activity.
  • The findings suggest that targeting or could be an effective strategy for overcoming resistance to TMZ in glioblastoma treatment, potentially allowing for lower doses of the drug.

Caveats

  • The study primarily focuses on in vitro models, which may not fully replicate the complexity of glioblastoma in vivo. Further research is needed to validate these findings in clinical settings.
  • The mechanisms by which regulates and affects stemness are not fully understood, indicating a need for more detailed investigations into these pathways.

Definitions

  • Glioblastoma stem cells (GSCs): A subpopulation of tumor cells in glioblastoma that exhibit stem cell-like properties and contribute to tumor recurrence.
  • Heat Shock Factor 1 (HSF1): A transcription factor that regulates the expression of heat shock proteins and is involved in cellular stress responses.
  • Bcl-2 interacting cell death suppressor (BIS): A protein that promotes cell survival and is regulated by HSF1, impacting apoptosis and cancer stem cell properties.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free